Pure Global
NCT03801486

Effects of Incorporating Sprouted and Non-sprouted Chickpea Flour in Pasta Products Analyzed in Vivo Flow-mediated Dilation

The Effects of Incorporating Sprouted and Non-sprouted Chickpea Flour in Pasta Products Analyzed in Vivo Flow-mediated Dilation
Montclair State University·ClinicalTrials.gov·otherCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Endothelial Dysfunction
Drug/Device/Intervention
Experimental: Sprouted Chickpea Flour
Study type
Observational
Intervention type
other
Sponsor & location
Primary sponsor
Montclair State University
Timeline & enrollment
Phase
N/A
Start date
Mar 02, 2016
End date
May 01, 2017
Enrollment
34 participants
Primary outcome

Post-digestion flow mediated dilation

Summary

The investigators examined the effects on post-digestion brachial artery flow mediated
 dilation (FMD) and in vitro antioxidant capacity of 40% semolina flour replacement with
 sprouted chickpea flour.

ICD-10 classifications
Other peripheral vascular diseasesAtherosclerosis of arteries of extremitiesOther specified peripheral vascular diseasesRenovascular hypertensionOther disorders of arteries and arterioles
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT03801486
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT03801486 through Pure Global AI's free database. This phase not specified trial is sponsored by Montclair State University and is currently Completed. The study focuses on Endothelial Dysfunction. Target enrollment is 34 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.